2026年欧洲癌症死亡预测:女性肺癌死亡率趋于平稳
该研究基于WHO和联合国数据库,用线性回归模型预测2026年欧盟及五国癌症死亡。女性肺癌死亡率在所有分析国家和整个欧盟趋于平稳(约12.5/10万),但西班牙例外(+2.4%);女性肺癌死亡下降仅限于65岁以下,老年组趋势不利。
要点
- 女性肺癌死亡率在欧盟及多数国家趋于平稳(约12.5/10万),西班牙例外上升2.4%。
- 女性肺癌死亡下降仅见于65岁以下,老年组趋势不利。
核心结论
- 2026年欧盟女性肺癌死亡率预测趋于平稳,存在年龄和国家差异。
- 欧盟和英国大多数癌症年龄标化死亡率趋势有利,但癌症死亡绝对数因人口老龄化未下降。
研究设计与样本
- 使用WHO和联合国数据库的癌症死亡证明和人口数据,覆盖欧盟及法国、德国、意大利、波兰、西班牙和英国。
- 基于Poisson joinpoint回归识别的最近年龄别趋势,用线性回归模型估计2026年死亡数。
- 通过将1988年峰值率应用于后续人口,计算1989至2026年间避免的死亡数。
主要发现
- 欧盟多数主要癌症趋势有利,但女性胰腺癌例外;英国多数趋势有利,但女性结直肠癌例外。
- 男性肺癌死亡率继续显著下降,女性肺癌死亡率在所有分析国家和整个欧盟趋于平稳(约12.5/10万),西班牙例外(+2.4%)。
- 女性肺癌死亡下降仅限于65岁以下,老年组趋势不利。
关键数值与推荐
- 女性肺癌死亡率趋于平稳,约12.5/10万,西班牙例外上升2.4%。
临床怎么用
- 关注女性肺癌死亡率趋于平稳及老年女性不利趋势,加强相应预防和筛查策略。
- 考虑人口老龄化导致癌症死亡绝对数不降,优化资源分配和姑息治疗规划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We provided updated cancer mortality estimates for 2026 in the European Union (EU) and its five most populous countries, with a focus on lung cancer. MATERIALS AND METHODS: Cancer death certifications and population data were obtained from the World Health Organization and United Nations databases. For the EU, France, Germany, Italy, Poland, Spain, and the UK, we derived data for all cancers combined and major cancer sites since 1970. Linear regression models, based on the most recent age-specific trends identified by Poisson joinpoint regression, were used to estimate deaths in 2026. The number of averted deaths between 1989 and 2026 was computed by applying the 1988 peak rate to subsequent populations. RESULTS: For 2026, we estimated ∼1 230 000 EU cancer deaths, corresponding to age-standardised rates of 114.1/100 000 males (-7.8% versus 2020-2022) and 74.7/100 000 females (-5.9%). In the EU countries and the whole EU, favourable trends are predicted for most major cancers, except female pancreatic cancer. In the UK, predicted rates are also favourable, except female colorectal cancer. Lung cancer mortality continues to decrease markedly among males, while we predicted a levelling off of rates, around 12.5/100 000, among females in all considered countries and the whole of EU, except for Spain (+2.4%). Among females, lung cancer mortality declines are confined to those aged <65 years, while unfavourable trends continued in older age groups. Around 7.3 (5.0 in males, 2.3 in females) million total cancer deaths have been avoided in the EU since the peak observed in 1988. The corresponding figure for lung cancer is 1.8 million among males, while no averted deaths were recorded among females. CONCLUSION: Lung cancer mortality predictions for 2026 indicate a levelling off among EU females, with age- and country-specific differences. Mortality trends in ASRs for most cancers remain favourable in the EU and the UK, though the absolute number of cancer deaths is not declining due to population ageing.
引用
- Santucci C, Mignozzi S, Levi F, et al. European cancer mortality predictions for the year 2026: the levelling of female lung cancer mortality. Ann Oncol. 2026. PMID: 41554652. doi:10.1016/j.annonc.2025.12.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。